Femasys (FEMY) Cash from Financing Activities (2020 - 2026)

Femasys (FEMY) posted Cash from Financing Activities of $342334.0 for Q1 2026, down 96.23% on a QoQ basis from $9.1 million in Q4 2025, and down 93.45% year-over-year from $5.2 million in Q1 2025.

Femasys (FEMY) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Femasys' Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $342334.0 for Q1 2026.

  • Quarterly Cash from Financing Activities fell 93.45% year-over-year to $342334.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.2 million (up 212.48% YoY) and the FY2025 annual result came in at $25.1 million, up 1139.74% from the prior year.
  • Cash from Financing Activities was $342334.0 for Q1 2026 at Femasys, down from $9.1 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $16.1 million in Q4 2023 and bottomed at -$362039.0 in Q3 2022.
  • A 5-year average of $2.9 million and a median of $824252.0 in 2023 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities sank 100.32% — and 2023, when it surged 19751.64%.
  • Femasys' Cash from Financing Activities stood at -$81950.0 in 2022, then jumped by 19751.64% to $16.1 million in 2023, then tumbled by 93.63% to $1.0 million in 2024, then jumped by 785.15% to $9.1 million in 2025, then slumped by 96.23% to $342334.0 in 2026.
  • Business Quant data shows FEMY's Cash from Financing Activities at $342334.0 in Q1 2026, $9.1 million in Q4 2025, and $7.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn -133.00 Mn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn -287.90 Mn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -414.00 Mn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -13.00 Mn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn -255.24 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn -164.80 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn -75.80 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn -50.00 Mn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn -48.13 Mn
10 Femasys 17.46 Mn 12.07 Mn - 342,334.00

Historic Data

Download Data
DateValue
Mar 31, 2026 342,334.00
Mar 31, 2026 342,334.00
Dec 31, 2025 9.08 Mn
Dec 31, 2025 9.08 Mn
Sep 30, 2025 6.98 Mn
Sep 30, 2025 6.98 Mn
Jun 30, 2025 3.85 Mn
Jun 30, 2025 3.85 Mn
Mar 31, 2025 5.23 Mn
Mar 31, 2025 5.23 Mn
Dec 31, 2024 1.03 Mn
Dec 31, 2024 1.03 Mn
Jun 30, 2024 223,549.00
Jun 30, 2024 223,549.00
Mar 31, 2024 778,175.00
Mar 31, 2024 778,175.00
Dec 31, 2023 16.10 Mn
Dec 31, 2023 16.10 Mn
Sep 30, 2023 870,329.00
Sep 30, 2023 870,329.00